#USA #Washington, D.C. #AI Technologies #cataract surgery #ZEISS

ZEISS Showcases Innovations at ASCRS 2026

At the upcoming ASCRS conference taking place from April 10-12, 2026, in Washington, D.C., ZEISS Medical Technology is set to unveil groundbreaking solutions designed to optimize workflows in cataract and refractive surgeries. As a leading institution in medical technology, ZEISS continues to push the envelope with innovative digital and artificial intelligence tools aimed at enhancing surgical experiences and patient outcomes.

New Technologies for Enhanced Efficiency

Among the highlights of ZEISS's presentation is the introduction of new irrigation and aspiration handpieces developed under the MicroSurgical Technology brand. These tools are compatible with the DORC EVA NEXUS surgical system and offer improved sustainability alongside a broader range of incision sizes, fitting into the company's commitment to enhance the efficiency of cataract workflows.

In addition, the updated ZEISS IOLMaster 700 is being showcased, which now includes expanded calculation capabilities through the Kane Suite and enhancements to the Barrett Suite. Surgeons will benefit from the new and refined formulas integrated into the ZEISS VERACITY Surgery Planner, including the Barrett RX formula and AI IOL Calculator designed specifically for post-lasik cataract patients. These advancements are meant to facilitate complex toric IOL calculations, thereby improving care for patients undergoing cataract surgery.

AI-Powered Patient Engagement

ZEISS is also excited to introduce the ZEISS VisioGen platform, a state-of-the-art AI-driven patient engagement solution tailored specifically for ophthalmology practices. This platform allows clinics to capture patient inquiries round-the-clock, ensuring that patients receive timely responses through AI assisted communications that are overseen by trained optometrists. Unlike typical automated systems, ZEISS VisioGen requires human validation for responses, striking a balance between efficiency and the necessary clinical oversight.

Dr. Dan Haddad, Medical Director at Laser Eye Institute in Troy, Michigan, elaborates on the care model, stating, "This approach combines the rapidity of AI interactions with an essential human touch to safeguard patient trust and ensure compliance with clinical standards."

Connecting Care with Cloud Solutions

Furthermore, ZEISS will highlight its Collaborative Care browser-based application aimed at facilitating seamless data sharing among eye care professionals. This application, powered by the ZEISS Health Data Platform, helps to strengthen cooperation among specialists, promoting a unified patient care journey. The goal is to diminish fragmentation that often occurs across different care settings, thus improving the overall experience for patients.

The ZEISS CLINIC 360 software is also set to be previewed, presenting an innovative solution for aggregating clinical data at scale, ultimately enhancing analytical capabilities in ophthalmic workflows.

Celebrating a Legacy of Innovation

As ZEISS commemorates 100 years of operation in the U.S. this year, it reflects on its legacy of pioneering medical devices such as surgical microscopes introduced in 1953. These instruments have continually evolved, now integrating advanced robotics and ergonomic designs to achieve the best patient outcomes while providing a better operational experience for surgeons.

With a focus on research and development, ZEISS seeks to reshape the standards of ophthalmic care through innovative alternatives that enhance patient experiences. The introduction of ZEISS SMILE, a minimally invasive laser vision correction procedure, underscores their commitment to cutting-edge surgical technology.

Attendees at ASCRS 2026 can visit ZEISS at booth #607 to engage directly with representatives and learn more about the latest innovations that are set to redefine surgical practices in eye care. For more information about their offerings, please visit zeiss.com/med.